Drug comparisons
Chlorpropamide vs Vildagliptin
Chlorpropamide (sulfonylurea) vs Vildagliptin (DPP-4 inhibitor): Chlorpropamide risks hypo and weight gain; Vildagliptin has lower side effects. Choice depends on patient profile.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when selecting between sulfonylureas and DPP-4 inhibitors for type 2 diabetes management.
Bottom line
Neither drug is inherently better; the choice between Chlorpropamide and Vildagliptin should be individualized based on patient-specific factors such as kidney function and risk of hypoglycemia.
All medication comparisons